Related Experiment Video
Updated: Aug 22, 2026

Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
Published on: January 8, 2020
A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas
Teiji Sawa1, Jeanine P Wiener-Kronish
1Department of Anesthesia and Perioperative Care, University of California San Francisco, 513 Parnassus, Med Sci S-261, San Francisco, CA 94143-0542, USA. teiji@itsa.ucsf.edu
Abstract:
Yersinia pestis, which causes pneumonic plague in healthy individuals, has the potential to be used for biologic warfare. Pseudomonas aeruginosis is an opportunistic pathogen that causes severe pneumonia in immunocompromised patients. There is evidence that these two pathogens use a highly homologous virulence mechanism, the type III secretion system. The type III secretion systems of both Yersinia and P. aeruginosa possess a protein named V-antigen which can be used as a target for immunotherapy against bioterrorism and opportunistic infections. This article summarizes the recent progress of V-antigen studies in Yersinia and P. aeruginosa.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Plague
Regulation of Bacterial Virulence
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis

